Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Classification, cancer-causing mechanisms, and cutting-edge molecular diagnostics of Fusobacterium nucleatum in colorectal cancer: bridging research and clinical application

  • By

  • Bin Li

  • Yifei Dong

  • Yifei Dai

  • Mengpei Zhang

  • Zhenwei Zou

  • Hai Yang

  • June 29, 2026

Share

  • 1

    Fusobacterium nucleatum is linked to colorectal cancer through mechanisms like oncogenic signaling activation and immune microenvironment modulation.

  • 2

    Technological advancements have improved Fn detection, transitioning from culture-based methods to high-resolution techniques like quantitative PCR and NGS.

  • 3

    Fn subspecies differentiation is crucial for understanding its role in CRC, with F. animalis associated with adverse clinical outcomes.

  • 4

    Current challenges in clinical translation of Fn diagnostics include subspecies heterogeneity and non-standardized diagnostic platforms.

  • 5

    Future research should focus on establishing a causal relationship between Fn and CRC, optimizing noninvasive detection, and developing targeted therapies.

Original Source(s)

Related Content